Skip to main content

Transforming the understanding
and treatment of mental illnesses.

Celebrating 75 Years! Learn More >>

Photo of Joshua A. Gordon, M.D., Ph.D.

Messages about Clinical Research and Trials

Bringing Innovation to the Search for Biomarkers

By Joshua Gordon on

In this Director’s Message, Dr. Gordon highlights research supported by the NIMH Small Business Innovation Research program that could advance the development of clinically relevant biomarkers.

From Brain Mechanisms to Novel Therapies: Understanding and Treating Eating Disorders

By Joshua Gordon on

In this message for National Eating Disorder Awareness Week, Dr. Gordon highlights NIMH-funded research aimed at reducing the impact of eating disorders.

Accelerating Science to Advance Early Interventions for Schizophrenia

By Joshua Gordon on

In this message, Dr. Gordon highlights a new public-private partnership that aims to develop novel treatment approaches that will make a meaningful difference in the lives of individuals at risk of schizophrenia.

A Plan for Mental Health Research

By Joshua Gordon on

This week, the National Institute of Mental Health unveiled its new NIMH Strategic Plan for Research. In this Director’s message, Dr. Gordon discusses the advances in knowledge and treatment that got us to where we are today and points to where we want our research to go in the future.

Addressing Disparities: Advancing Mental Health Care for All Americans

By Joshua Gordon on

Mental health disparities are significant and easily documented. In this Director’s Message, Dr. Gordon discusses NIMH-funded research that aims to close the gap, ensuring that improved mental health care meets the needs of all Americans.

Harnessing the Power of Technology for Mental Health

By Joshua Gordon on

In this Director’s Message, Dr. Gordon discusses the potential that technology holds for expanding the reach of mental health care.

New Hope for Treatment-Resistant Depression: Guessing Right on Ketamine

By Joshua Gordon on

In his latest message, Dr. Gordon discusses the role of NIMH and other researchers in the development of esketamine, an FDA-approved, rapid-acting medication that targets treatment-resistant depression.

A Bench-to-Bedside Story: The Development of a Treatment for Postpartum Depression

By Joshua Gordon on

In this message, Dr. Gordon discusses the role of NIMH and others in the bench-to-bedside story of brexanolone, which has just been approved by the FDA as the first treatment specifically for postpartum depression.

Summer Reading

By Joshua Gordon on

Dr. Gordon offers highlights of his summer reading in science and literature.

An Experimental Therapeutic Approach to Psychosocial Interventions

By Joshua Gordon on

Dr. Gordon talks about NIMH’s commitment to support the development and testing of psychosocial interventions in the greater context of the experimental therapeutics approach to treatment research.